Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Reward responsiveness and fatigue in multiple sclerosis.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
AMP-Activated Protein Kinase Restricts IFN-γ Signaling.
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Towards establishing MS prevalence in Latin America and the Caribbean.
Alteration of CD1 expression in multiple sclerosis.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Psychiatric disorders in neurology.
The risk of Bipolar Disorders in Multiple Sclerosis.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Risk of vascular disease in patients with multiple sclerosis: a review.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Pages
« first
‹ previous
…
180
181
182
183
184
185
186
187
188
…
next ›
last »